GlassScriptPhysician profile
Arlene Carungcong
NPI 1407193121
$11,123.10
in general payments reported to CMS, 2019-2025
27 companies · $1,858 in 2025
The $1,858 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,164 · 2022: $2,249 · 2023: $2,526 · 2024: $2,326 · 2025: $1,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,709.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $2,450.95 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,276.75 | 2021-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $1,855.21 | 2021-2025 | Belbuca, Nucynta, Xtampza |
| Scilex Pharmaceuticals INC. | $1,279.57 | 2021-2025 | Ztlido |
| Ibsa Pharma INC. | $905.97 | 2021-2025 | Tirosint, Licart, Tirosint |
| Protega Pharmaceutials INC | $389.88 | 2024-2025 | Roxybond |
| Abbvie INC. | $381.59 | 2021-2025 | |
| Redhill Biopharma INC. | $218.04 | 2021-2023 | Movantik, Aemcolo, Talicia |
| Arbor Pharmaceuticals, INC. | $175.98 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $166.15 | 2022-2023 | Seglentis |
| Abbott Laboratories | $160.45 | 2024 | Proclaim |
| Nevro Corp. | $138.28 | 2023 | Senza |
| Horizon Therapeutics Plc | $129.36 | 2021-2022 | |
| Amgen INC. | $87.70 | 2021-2022 | |
| Pfizer INC. | $83.15 | 2021-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $61.69 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $57.35 | 2021 | |
| Medtronic, INC. | $52.01 | 2022 | |
| Radius Health, INC. | $47.99 | 2021-2023 | Tymlos |
| Lilly USA, LLC | $34.98 | 2021 | |
| Eisai INC. | $33.39 | 2021 | |
| Merck Sharp & Dohme LLC | $28.76 | 2022 | |
| Almatica Pharma LLC | $27.89 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $27.27 | 2023-2025 | Horizant, Horizant |
| Impel Pharmaceuticals INC. | $19.31 | 2022 | |
| Painteq LLC | $17.33 | 2024 | Painteq |
| E.R. Squibb & Sons, L.L.C. | $16.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Carungcong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.